Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve As per attachment.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Norris Medicines Ltd has informed BSE that a board meeting is scheduled for May 30, 2026 at the company's registered office in Ankleshwar, Gujarat. The meeting will consider and approve the audited financial results for the quarter and year ended March 31, 2026, along with the audit report, cash flow statement, statement of assets and liabilities, and a declaration for un-modified audit opinion. The company has confirmed that the trading window has been closed since April 1, 2026, and will remain closed until 48 hours after the results are declared on the stock exchange.
This is a routine board meeting intimation for quarterly and annual results. The mention of an un-modified opinion declaration suggests a clean audit opinion with no qualifications, which is typically positive for investors. The closed trading window prevents insider trading ahead of the results announcement.